|
GB201004551D0
(en)
*
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
|
|
EP2569633B1
(en)
|
2010-05-14 |
2016-02-10 |
The General Hospital Corporation |
Compositions and methods of identifying tumor specific neoantigens
|
|
PL3892295T3
(pl)
|
2011-05-24 |
2023-07-24 |
BioNTech SE |
Zindywidualizowane szczepionki przeciwnowotworowe
|
|
WO2013081721A1
(en)
*
|
2011-11-30 |
2013-06-06 |
Battelle Memorial Institute |
Biomarkers for lymphoma
|
|
LT2901341T
(lt)
|
2012-09-28 |
2019-09-25 |
The University Of Connecticut |
Protekcinių vėžio epitopų identifikavimas, skirtas vėžio gydymui
|
|
ES3009756T3
(en)
|
2013-08-05 |
2025-03-31 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against several tumors, such as lung cancer including nsclc
|
|
TWI636065B
(zh)
|
2013-08-05 |
2018-09-21 |
伊瑪提克斯生物科技有限公司 |
新穎肽類,細胞及其用於治療多種腫瘤的用途,其製造方法及包含其等之醫藥組成物
|
|
GB201319446D0
(en)
|
2013-11-04 |
2013-12-18 |
Immatics Biotechnologies Gmbh |
Personalized immunotherapy against several neuronal and brain tumors
|
|
WO2015077717A1
(en)
|
2013-11-25 |
2015-05-28 |
The Broad Institute Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
|
|
WO2015085147A1
(en)
|
2013-12-05 |
2015-06-11 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
|
KR20230076867A
(ko)
|
2013-12-20 |
2023-05-31 |
더 브로드 인스티튜트, 인코퍼레이티드 |
신생항원 백신과의 병용 요법
|
|
GB201408255D0
(en)
|
2014-05-09 |
2014-06-25 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against several tumours of the blood, such as acute myeloid leukemia (AML)
|
|
GB201411037D0
(en)
|
2014-06-20 |
2014-08-06 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemai (CLL)
|
|
US11338026B2
(en)
|
2014-09-10 |
2022-05-24 |
The University Of Connecticut |
Identification of immunologically protective neo-epitopes for the treatment of cancers
|
|
CN113791220A
(zh)
*
|
2014-09-10 |
2021-12-14 |
豪夫迈·罗氏有限公司 |
免疫原性突变体肽筛选平台
|
|
US10975442B2
(en)
|
2014-12-19 |
2021-04-13 |
Massachusetts Institute Of Technology |
Molecular biomarkers for cancer immunotherapy
|
|
EP3234130B1
(en)
|
2014-12-19 |
2020-11-25 |
The Broad Institute, Inc. |
Methods for profiling the t-cell- receptor repertoire
|
|
MA49156A
(fr)
|
2014-12-23 |
2020-03-25 |
Immatics Biotechnologies Gmbh |
Nouveaux peptides et combinaison de peptides à utiliser dans l'immunothérapie contre le carcinome hépatocellulaire (hcc) et d'autres cancers
|
|
GB201501017D0
(en)
|
2014-12-23 |
2015-03-04 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
|
|
GB201423361D0
(en)
*
|
2014-12-30 |
2015-02-11 |
Immatics Biotechnologies Gmbh |
Method for the absolute Quantification of naturally processed HLA-Restricted cancer peptides
|
|
LT3388075T
(lt)
|
2015-03-27 |
2023-11-10 |
Immatics Biotechnologies Gmbh |
Nauji peptidai ir peptidų deriniai, skirti naudoti imunoterapijai prieš įvairius navikus (seq id 25 - mrax5-003)
|
|
GB201505585D0
(en)
|
2015-03-31 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers
|
|
GB201507030D0
(en)
|
2015-04-24 |
2015-06-10 |
Immatics Biotechnologies Gmbh |
Immunotherapy against lung cancers, in particular NSCLC
|
|
GB201507719D0
(en)
|
2015-05-06 |
2015-06-17 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
|
|
EA201792501A1
(ru)
|
2015-05-13 |
2018-10-31 |
Эйдженус Инк. |
Вакцины для лечения и профилактики рака
|
|
IL294183B2
(en)
|
2015-05-20 |
2023-10-01 |
Dana Farber Cancer Inst Inc |
shared neoantigens
|
|
GB201511191D0
(en)
|
2015-06-25 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
T-cell epitopes for the immunotherapy of myeloma
|
|
HK1254866A1
(zh)
|
2015-06-25 |
2019-07-26 |
Immatics Biotechnologies Gmbh |
用於骨髓瘤和其他癌症免疫治疗的新型细胞表位和细胞表位组合物
|
|
MA54884A
(fr)
|
2015-07-01 |
2022-01-12 |
Immatics Biotechnologies Gmbh |
Neuartige peptide und kombination aus peptiden zur verwendung in der immuntherapie gegen ovarialkarzinom und andere karzinome
|
|
GB201511546D0
(en)
|
2015-07-01 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
|
GB201511792D0
(en)
|
2015-07-06 |
2015-08-19 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against esopageal cancer and other cancers
|
|
CR20230563A
(es)
|
2015-07-06 |
2024-01-22 |
Immatics Biotechnologies Gmbh |
NUEVOS PÉPTIDOS Y COMBINACIÓN DE PÉPTIDOS PARA USAR EN INMUNOTERAPIA CONTRA EL CÁNCER ESOFÁGICO Y OTROS CÁNCERES (Divisional Exp. 2017-0579)
|
|
MY189596A
(en)
*
|
2015-07-15 |
2022-02-18 |
Immatics Biotechnologies Gmbh |
A novel peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
|
|
GB201513921D0
(en)
|
2015-08-05 |
2015-09-23 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
|
|
TWI782434B
(zh)
|
2015-08-28 |
2022-11-01 |
德商英麥提克生物技術股份有限公司 |
用於多種癌症之免疫治療的新穎胜肽、胜肽的組合物及支架
|
|
US10335471B2
(en)
|
2015-08-28 |
2019-07-02 |
Immatics Biotechnologies Gmbh |
Method for treating cancer with activated T cells
|
|
PH12022551111A1
(en)
|
2015-10-05 |
2023-08-23 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
|
|
GB201517538D0
(en)
|
2015-10-05 |
2015-11-18 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
|
|
EP3362929B1
(en)
*
|
2015-10-12 |
2020-08-12 |
Nantomics, LLC |
Viral neoepitopes and uses thereof
|
|
MX2018004544A
(es)
|
2015-10-12 |
2018-11-09 |
Nantomics Llc |
Composiciones y métodos para los neoepítopos de cáncer viral.
|
|
GB201522667D0
(en)
|
2015-12-22 |
2016-02-03 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
|
|
MA55153A
(fr)
|
2016-02-19 |
2021-09-29 |
Immatics Biotechnologies Gmbh |
Nouveaux peptides et combinaison de peptides pour une utilisation dans l'immunothérapie contre le lymphome non hodgkinien et d'autres cancers
|
|
GB201602918D0
(en)
*
|
2016-02-19 |
2016-04-06 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against NHL and other cancers
|
|
IL302705A
(en)
|
2016-03-01 |
2023-07-01 |
Immatics Biotechnologies Gmbh |
Peptides, combinations of peptides, cell-based drugs for use in immunotherapy against bladder cancer and other types of cancer
|
|
GB201603987D0
(en)
|
2016-03-08 |
2016-04-20 |
Immatics Biotechnologies Gmbh |
Uterine cancer treatments
|
|
GB201604458D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against cancers
|
|
CN109071605A
(zh)
|
2016-04-06 |
2018-12-21 |
伊玛提克斯生物技术有限公司 |
用于aml和其他癌症免疫治疗的新型肽和肽组合物
|
|
AU2017254477A1
(en)
*
|
2016-04-18 |
2018-11-01 |
Jennifer G. ABELIN |
Improved HLA epitope prediction
|
|
TWI796299B
(zh)
|
2016-08-26 |
2023-03-21 |
德商英麥提克生物技術股份有限公司 |
用於頭頸鱗狀細胞癌和其他癌症免疫治療的新型肽和支架
|
|
DE102016123893A1
(de)
|
2016-12-08 |
2018-06-14 |
Immatics Biotechnologies Gmbh |
T-Zellrezeptoren mit verbesserter Bindung
|
|
KR102379955B1
(ko)
|
2016-12-08 |
2022-03-29 |
이매틱스 바이오테크놀로지스 게엠베하 |
짝짓기가 향상된 t 세포 수용체
|
|
US11549149B2
(en)
|
2017-01-24 |
2023-01-10 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
|
SI3573647T1
(sl)
|
2017-01-27 |
2023-07-31 |
Immatics Biotechnologies Gmbh |
Peptidi in kombinacija peptidov za uporabo v imunoterapiji proti raku jajčnikov in drugim oblikam raka
|
|
WO2018138257A1
(en)
|
2017-01-27 |
2018-08-02 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
|
US10738100B2
(en)
|
2017-01-27 |
2020-08-11 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
|
CA3058807A1
(en)
|
2017-04-03 |
2018-10-11 |
Biontech Us Inc. |
Protein antigens and uses thereof
|
|
EA201992416A1
(ru)
|
2017-04-10 |
2020-02-25 |
Имматикс Байотекнолоджиз Гмбх |
Пептиды и комбинации пептидов для применения в иммунотерапии лейкозов и других видов рака
|
|
WO2018189148A1
(en)
|
2017-04-10 |
2018-10-18 |
Immatics Biotechnologies Gmbh |
Peptides and combination thereof for use in the immunotherapy against cancers
|
|
BR112019020959A2
(pt)
|
2017-04-10 |
2020-05-05 |
Immatics Biotechnologies Gmbh |
peptídeos e combinações dos mesmos para uso na imunoterapia contra câncer
|
|
WO2018224166A1
(en)
|
2017-06-09 |
2018-12-13 |
Biontech Rna Pharmaceuticals Gmbh |
Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy
|
|
MX2019015879A
(es)
|
2017-07-07 |
2020-02-07 |
Immatics Biotechnologies Gmbh |
Nuevos peptidos y nuevas combinacones de peptidos para el uso en la inmunoterapia contra el cancer de pulmon, incluyendo el nsclc, el sclc y otros canceres.
|
|
US10800823B2
(en)
|
2017-07-07 |
2020-10-13 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
|
|
TW201930340A
(zh)
|
2017-12-18 |
2019-08-01 |
美商尼恩醫療公司 |
新抗原及其用途
|
|
DE102018107224A1
(de)
|
2018-02-21 |
2019-08-22 |
Immatics Biotechnologies Gmbh |
Peptide und Kombinationen von Peptiden nicht-kanonischen Ursprungs zur Verwendung in der Immuntherapie gegen verschiedene Krebsarten
|
|
MA52363A
(fr)
|
2018-04-26 |
2021-03-03 |
Agenus Inc |
Compositions peptidiques de liaison à une protéine de choc thermique (hsp) et leurs méthodes d'utilisation
|
|
TW202016131A
(zh)
|
2018-05-16 |
2020-05-01 |
德商英麥提克生物技術股份有限公司 |
用於抗癌免疫治療的肽
|
|
MX2020014243A
(es)
|
2018-06-19 |
2021-05-12 |
Biontech Us Inc |
Neoantigenos y usos de los mismos.
|
|
US10925947B2
(en)
|
2018-06-29 |
2021-02-23 |
Immatics Biotechnologies Gmbh |
A*03 restricted peptides for use in immunotherapy against cancers and related methods
|
|
CN109002689B
(zh)
*
|
2018-07-23 |
2020-10-09 |
西安交通大学医学院第一附属医院 |
T细胞数据处理方法及装置
|
|
TW202019955A
(zh)
|
2018-07-31 |
2020-06-01 |
德商英麥提克生物技術股份有限公司 |
B*07 限制肽和肽組合的抗癌免疫治療和相關方法
|
|
DE102018122546B3
(de)
|
2018-09-14 |
2019-12-05 |
Immatics Biotechnologies Gmbh |
Verfahren zum Hochdurchsatz-Peptid-MHC-Affinitätsscreening für TCR-Liganden
|
|
TW202028224A
(zh)
|
2018-09-17 |
2020-08-01 |
德商英麥提克生物技術股份有限公司 |
B*44限制肽在抗癌免疫治療的用途和相關方法
|
|
TW202024121A
(zh)
|
2018-09-18 |
2020-07-01 |
德商英麥提克生物技術股份有限公司 |
A*01 限制肽和肽組合物在抗癌免疫治療中的用途和相關方法
|
|
TW202039535A
(zh)
|
2018-12-18 |
2020-11-01 |
德商英麥提克生物技術股份有限公司 |
B*08限制肽和肽組合物抗癌免疫治療和相關方法
|
|
WO2020245839A1
(en)
*
|
2019-06-06 |
2020-12-10 |
Dr. Reddy's Laboratories Limited |
Method for identification and absolute quantification of product-related impurities in a protein using high-resolution mass spectrometry
|
|
DE102019121007A1
(de)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
|
US20210032370A1
(en)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
|
JP2022543687A
(ja)
|
2019-08-09 |
2022-10-13 |
イマティクス ユーエス,アイエヌシー. |
ペプチド質量分析断片化を予測するための方法
|
|
US12480958B2
(en)
|
2019-08-13 |
2025-11-25 |
Immatics Biotechnologies Gmbh |
Method for the characterization of peptide:MHC binding polypeptides
|
|
IL269564B2
(en)
|
2019-09-23 |
2023-11-01 |
Keter Home & Garden Products Ltd |
Sawhorse
|
|
US11920202B2
(en)
|
2020-04-09 |
2024-03-05 |
University Of Connecticut |
Unbiased identification of tumor rejection mediating neoepitopes
|
|
CA3183756A1
(en)
|
2020-05-19 |
2021-11-25 |
Amgen Inc. |
Mageb2 binding constructs
|
|
TW202229312A
(zh)
|
2020-09-29 |
2022-08-01 |
德商英麥提克生物技術股份有限公司 |
由非hla-a*02顯露以用於不同類型癌症之免疫治療的醯胺化肽及其脫醯胺化對應物
|
|
DE102020125457A1
(de)
|
2020-09-29 |
2022-03-31 |
Immatics Biotechnologies Gmbh |
Amidierte Peptide und ihre deamidierten Gegenstücke, die durch HLA-A*02-Moleküle präsentiert werden, zur Verwendung in der Immuntherapie gegen verschiedene Krebsarten
|
|
DE102020125465A1
(de)
|
2020-09-29 |
2022-03-31 |
Immatics Biotechnologies Gmbh |
Amidierte Peptide und ihre deamidierten Gegenstücke, die durch nicht-HLA-A*02-Moleküle präsentiert werden, zur Verwendung in der Immuntherapie gegen verschiedene Krebsarten
|
|
US11421015B2
(en)
|
2020-12-07 |
2022-08-23 |
Think Therapeutics, Inc. |
Method of compact peptide vaccines using residue optimization
|
|
US11058751B1
(en)
|
2020-11-20 |
2021-07-13 |
Think Therapeutics, Inc. |
Compositions for optimized RAS peptide vaccines
|
|
CN116710115A
(zh)
|
2020-11-20 |
2023-09-05 |
思维疗法股份有限公司 |
用于优化的肽疫苗的组合物和方法
|
|
US11161892B1
(en)
|
2020-12-07 |
2021-11-02 |
Think Therapeutics, Inc. |
Method of compact peptide vaccines using residue optimization
|
|
TW202241925A
(zh)
|
2021-01-15 |
2022-11-01 |
德商英麥提克生物技術股份有限公司 |
用於不同類型癌症免疫治療的hla展示肽
|
|
US11464842B1
(en)
|
2021-04-28 |
2022-10-11 |
Think Therapeutics, Inc. |
Compositions and method for optimized peptide vaccines using residue optimization
|
|
WO2022233956A1
(en)
|
2021-05-05 |
2022-11-10 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins specifically binding prame
|
|
PE20240779A1
(es)
|
2021-07-27 |
2024-04-17 |
Immatics Biotechnologies Gmbh |
Proteinas de union a antigenos que se unen especificamente a ct45
|
|
US12531162B1
(en)
*
|
2023-05-31 |
2026-01-20 |
Northeastern University |
Multi-dimensional phenotypic space for genotype to phenotype mapping and intelligent design of cancer drug therapies using a deep learning net
|
|
WO2025021979A1
(en)
|
2023-07-27 |
2025-01-30 |
Immatics Biotechnologies Gmbh |
Novel t cell receptors targeting melanoma-associated antigen (mage) b2 and immune therapy using the same
|
|
CN121358777A
(zh)
|
2023-07-27 |
2026-01-16 |
伊玛提克斯生物技术有限公司 |
抗mageb2的抗原结合蛋白
|
|
WO2025040598A2
(en)
|
2023-08-18 |
2025-02-27 |
Immatics Biotechnologies Gmbh |
Peptides displayed by mhc for use in immunotherapy against different types of cancer
|
|
US12562256B2
(en)
*
|
2023-11-07 |
2026-02-24 |
New York University |
Systems, methods and computer-accessible medium for identifying target pairs for CAR-T therapy
|
|
WO2025125535A1
(en)
*
|
2023-12-13 |
2025-06-19 |
Immatics Biotechnologies Gmbh |
Differential population-scale immunopeptidomics
|
|
WO2025233431A1
(en)
|
2024-05-07 |
2025-11-13 |
Immatics Biotechnologies Gmbh |
Heteromeric proteins comprising three heteromerization improving substitution, production, combinations and applications thereof
|
|
WO2025233432A1
(en)
|
2024-05-07 |
2025-11-13 |
Immatics Biotechnologies Gmbh |
Use and dosage of an antigen-binding protein comprising a tcr specific for an hla-a*02 restricted peptide
|
|
WO2026008886A1
(en)
|
2024-07-05 |
2026-01-08 |
Immatics Biotechnologies Gmbh |
Means and methods for the quantification of target expression
|
|
WO2026033136A1
(en)
|
2024-08-09 |
2026-02-12 |
Immatics Biotechnologies Gmbh |
Advanced treatment modalities for anti-prame tcr-engineered immune cells
|